Exploring nor-LSD. To explore a different substance…

d-nor-Lysergic acid diethylamide
IUPAC name:
5346 · C19H23N3O · 309.405
SUXLVXOMPKZBOV-CXAGYDPISA-N This stereoisomer Any stereoisomer

Meyers-Riggs, B. Non-LSD ergoloids. countyourculture, countyourculture: rational exploration of the underground, 1 Dec 2011.

Stachulski, AV; Nichols, DE; Scheinmann, F. Stereochemical and NMR reassignment of 6-norlysergic acid diethylamide and 6-nor-6-allyllysergic acid diethylamide. J. Chem. Research (S), 1 Jan 1996, 30–31. 4.0 MB.

Martin, R. Nachweis und Bestimmung halluzinogener Wirkstoffe und ihrer Metaboliten in Körperflüssigkeiten und Haaren. Toxichem Krimtech, 1 Jan 2015, 82 (2), 123–127. 448 kB.

Nichols, DE. Dark classics in chemical neuroscience: Lysergic acid diethylamide (LSD). ACS Chem. Neurosci., 20 Feb 2018, n/a. 1.1 MB. https://doi.org/10.1021/acschemneuro.8b00043

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1994; pp 74–91. 51 kB.

Hoffman, AJ. Synthesis and pharmacological evaluation of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives. Ph. D. Thesis, Purdue University, 1 Aug 1987. 9.3 MB. #8

Passie, T; Halpern, JH; Stichtenoth, DO; Emrich, HM; Hintzen, A. The pharmacology of lysergic acid diethylamide: A review. CNS Neurosci. Ther., 1 Jan 2008, 14 (4), 295–314. 690 kB. https://doi.org/10.1111/j.1755-5949.2008.00059.x

IPLA · N-Isopropyllysergamide
19 September 2018 · Creative Commons BY-NC-SA ·